ADVANCED TECHNOLOGY INTERNATIONAL - OTHER TRANSACTION: PRODUCTION OF THREE (3) BIOLOGICALLY DERIVED SMALL MOLECULE REGULATORY STARTING MATERIALS AND/OR ACTIVE PHARMACEUTICAL INGREDIENTS AT COMMERCIAL SCALE UNDER THE BIOMAP-CONSORTIUM
Key Details
Description
OTHER TRANSACTION: PRODUCTION OF THREE (3) BIOLOGICALLY DERIVED SMALL MOLECULE REGULATORY STARTING MATERIALS AND/OR ACTIVE PHARMACEUTICAL INGREDIENTS AT COMMERCIAL SCALE UNDER THE BIOMAP-CONSORTIUM
Context & Analysis
On Feb 23, 2026, Department of Health and Human Services obligated $32,000,000 to ADVANCED TECHNOLOGY INTERNATIONAL for other transaction: production of three (3) biologically derived small molecule regulatory starting materials and/or active pharmaceutical ingredients at commercial scale under the biomap-consortium. The award is classified under NAICS 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in SUMMERVILLE, SC. The contract is scheduled through Dec 31, 2027. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325414 — related awards are listed below.
Contractor Information
Similar Awards
DEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES
SANOFI VACCINES US INC.
$612.2M
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
ADVANCED TECHNOLOGY INTERNATIONAL
$304.0M
EXPANSION OF PRODUCTION CAPACITY OF MAN-MADE FABRIC FOR MANUFACTURING DISPOSABLE MEDICAL GOWNS
ADVANCED TECHNOLOGY INTERNATIONAL
$248.5M
OTHER TRANSACTION: PROCUREMENT AND SUSTAINMENT OF N95 MASK MANUFACTURING CAPACITY UNDER THE BIOMAP-CONSORTIUM.
ADVANCED TECHNOLOGY INTERNATIONAL
$141.3M
EXPANSION OF DOMESTIC MANUFACTURING CAPACITY FOR NITRILE GLOVES
ADVANCED TECHNOLOGY INTERNATIONAL
$61.0M
Stay Updated
Get notified about new opportunities matching your interests.